Table:
begin	end	state
1	27	cytoplasmic
28	48	transmembrane
49	52	non-cytoplasmic
53	72	transmembrane
73	80	cytoplasmic
81	104	transmembrane
105	288	non-cytoplasmic
289	312	transmembrane
313	323	cytoplasmic
324	348	transmembrane
349	378	non-cytoplasmic
379	402	transmembrane
403	431	cytoplasmic
432	455	transmembrane
456	491	non-cytoplasmic
492	514	transmembrane
515	521	cytoplasmic

Input:
>WP_090447143.1 NCBI__GCF_900100495.1:WP_090447143.1
MTAMNAPAELASPAMPKYFSLPVLRKTLHWAVWGLFNALALYLVVALYAQQQIAFALLGL
VVTGLASFIFISKKTYAHRYIYPALAGMLVFVIFPLLYTVGIGFTNYSGSNLLSFEQVQR
YHLNQTYLAGERFAFSLHQDAAGALRLRVDQGEKGLFVSPPLQGDPALSEPLDLLPETSV
SLGAALPLREVIQRRAELERWVLRGEQGELLRLYGLREVAAVKPLFRLLEDGDLQNTRSG
EVLSADQDIGFYVDSHGAKVAPGFTVYAGASNFAKVLTDPSIRAPFLEIFVWTVAFAGLT
VLFTLAVGLLLASLLQWDLVGGKAFYRVMLILPYAVPAFISILVFRGLFNQNFGEINLLL
DSLFGMRPDWFSDPTLARGMILLVNTWLGYPYMLLLCMGLLQAIPRDLYEASAMDGATPL
DNLLKITLPLLIKPLAPLLIASFAFNFNNFVLITLLTRGGPDIIGATTPAGTTDLLVSYT
YRIAFQDSGQNFALAAAIATLIFLVVGGMAWLNLKLSKVKV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server